Effects of dipeptidyl peptidase-4 inhibitor in insulin-resistant rats with myocardial infarction
© 2016 Society for Endocrinology. Adverse cardiac remodeling after myocardial infarction (MI) leads to progressive heart failure. Obese-insulin resistance increases risks of MI and heart failure. Although dipeptidyl peptidase-4 (DPP4) inhibitor is known to exert cardioprotection, its effects on adve...
Saved in:
Main Authors: | Apaijai N., Inthachai T., Lekawanvijit S., Chattipakorn S., Chattipakorn N. |
---|---|
Format: | Journal |
Published: |
2017
|
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84977659591&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/42288 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Effects of dipeptidyl peptidase-4 inhibitor in insulin-resistant rats with myocardial infarction
by: Nattayaporn Apaijai, et al.
Published: (2018) -
Dipeptidyl peptidase-4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction
by: Inthachai T., et al.
Published: (2015) -
Dipeptidyl peptidase-4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction
by: Inthachai T., et al.
Published: (2015) -
Dipeptidyl peptidase-4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction
by: Tharnwimol Inthachai, et al.
Published: (2018) -
Dipeptidyl peptidase-4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction
by: Tharnwimol Inthachai, et al.
Published: (2018)